BlackRock Japan’s Dare Bioscience DARE Stock Holding History

BlackRock Japan’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-38	Closed	-$12K	–	1437
2016 Q1	$12K	Buy	38 +9	+31%	+$2.54K	﹤0.01%	1259
2015 Q4	$10K	Buy	29 +4	+16%	+$1.66K	﹤0.01%	1260
2015 Q3	$11K	Hold	25	–	–	﹤0.01%	1155
2015 Q2	$14K	Buy	+25	New	+$17.2K	﹤0.01%	1237

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVMCI

Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock Japan's DARE Position: Q2 2016 in Review

BlackRock Japan sold out of Dare Bioscience (DARE) in Q2 2016, closing a stake of 38 shares — an estimated $12K sold.

BlackRock Japan first reported a position in DARE in Q2 2015 and held it in 4 quarters. The position peaked at $14K in Q2 2015. 34 funds tracked by Wall St. Rank hold DARE as of Q2 2016.

BlackRock Japan reported no remaining Dare Bioscience position as of Q2 2016 after selling out during the quarter.
BlackRock Japan sold 38 Dare Bioscience shares in Q2 2016, an estimated $12K.
BlackRock Japan first reported a position in Dare Bioscience in Q2 2015 and held it in 4 quarters.
BlackRock Japan's Dare Bioscience position peaked at $14K in Q2 2015.
34 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2016.

Based on BlackRock Japan's 13F filing for Q2 2016, filed 10 Aug 2016.